Lighthouse Psychiatry Brain Health Center
4001 East Baseline Road, Suite 204, Gilbert
4.6(950 Google reviews)
United States
7 listed treatment centers serving Gilbert and the surrounding area.
4001 East Baseline Road, Suite 204, Gilbert
4.6(950 Google reviews)
2730 South Val Vista Drive, Suite 146 Bldg 8, Gilbert
4.3(559 Google reviews)
2450 East Guadalupe Road, Suite 103, Gilbert
4.4(41 Google reviews)
3126 South Higley Road, 104, Gilbert
5.0(4 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Gilbert.
3.4 miles away · Chandler
1915 East Chandler Boulevard, Suite 1, Chandler
4.3(412 Google reviews)
4.1 miles away · Chandler
4.4 miles away · Chandler
1347 North Alma School Road, Suite 120, Chandler
4.8(16 Google reviews)
4.4 miles away · Chandler
1347 North Alma School Road, Suite 120, Chandler
4.6(415 Google reviews)
4.8 miles away · Chandler
575 West Chandler Boulevard, 225, Chandler
5.0(14 Google reviews)
6.1 miles away · Chandler
The cost of SPRAVATO® treatment depends on your insurance benefits, the treatment setting, and the services billed. Both the medication and the supervised treatment visit, including observation and monitoring, may generate charges. Ask for an estimate that separates these components rather than assuming one quoted charge covers everything.
Before starting, check whether your plan requires prior authorization. Insurers commonly request documentation of earlier antidepressant trials. Your prescriber may need records showing which medications you tried, how long you took them, and your response. Ask who will collect those records and submit the authorization request. An authorization is not a guarantee that every charge will be paid.
Medicare may cover Spravato through Part B or Part D, depending on the plan and treatment setting. Arizona Medicaid coverage also depends on the plan and applicable requirements. Confirm benefits directly with your insurer and ask the center whether it can bill your coverage for both the medication and monitoring services.
Manufacturer savings programs exist for some eligible commercially insured patients, but not for patients using government insurance. Program terms and eligibility restrictions apply; do not count on assistance until your eligibility is confirmed.
Before scheduling, ask the center and insurer:
SPRAVATO® treatment requires repeat visits to a REMS-certified healthcare setting. You administer the nasal spray yourself under a healthcare provider’s direct observation; it is never dispensed for home use.
This directory currently has no listed treatment center in Gilbert. The supplied directory information also identifies no other Arizona cities with listed centers, so there is no nearby listed city to recommend here. Ask your prescribing clinician or insurer for help locating a treatment setting, then verify its current REMS certification directly before scheduling. An insurance directory listing alone should not substitute for that check.
For treatment-resistant depression, the typical labeled schedule starts twice weekly during weeks 1–4, then weekly during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber will individualize the schedule; do not assume your appointments will follow a fixed long-term pattern.
Each visit includes at least two hours of monitoring after the dose, with additional time potentially needed for check-in, preparation, or further observation. Plan time off work around the full appointment and travel, not just the monitoring period. Discuss any safety-sensitive work with your treatment team.
Arrange for someone else to drive you home after every visit. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its transportation and escort requirements before relying on a paid ride service. Consider a backup driver, coordinate recurring rides early, and tell the center before your appointment if transportation falls through.
This directory currently has no listed SPRAVATO® treatment center in Gilbert and no other listed Arizona cities to point you toward. Ask your clinician or insurer to help identify a treatment setting. Before making an appointment, confirm directly that the location is REMS-certified, is accepting new patients, and can evaluate you for treatment. Certification and insurance network participation are separate questions.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A prescriber must assess your diagnosis, treatment history, and safety considerations; meeting an approved indication does not automatically mean treatment is appropriate for you.
Coverage depends on your plan and the treatment setting. Prior authorization and records of earlier antidepressant trials are common requirements. Ask your insurer about both the medication and the monitored visit, including network status and your share of costs. Medicare and Arizona Medicaid may cover treatment depending on the plan and setting, but coverage cannot be assumed. Ask the center who handles authorization and ongoing coverage checks.
You self-administer the nasal spray at a REMS-certified healthcare setting while a healthcare provider observes you. The team monitors you for at least two hours afterward, including for sedation, dissociation, breathing problems, and blood pressure increases. Your visit may take longer than two hours overall. Arrange a driver home: you cannot drive or operate machinery until the next day after a restful sleep.
Important risks include sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Review your medical history and medications with the prescriber, and tell staff immediately if you feel unwell during monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Its approval for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior requires use with an oral antidepressant. If you are in crisis, call or text 988. If you are in immediate danger or need emergency medical help, call 911 rather than waiting for a treatment appointment.
Approved uses, nearby treatment centers, and medically sourced patient guides.